Detalhe da pesquisa
1.
Long-term survival with first-line nivolumab plus ipilimumab in patients with advanced non-small-cell lung cancer: a pooled analysis.
Ann Oncol
; 34(2): 173-185, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36414192
2.
Nivolumab plus chemotherapy in first-line metastatic non-small-cell lung cancer: results of the phase III CheckMate 227 Part 2 trial.
ESMO Open
; 8(6): 102065, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37988950
3.
First-line nivolumab + ipilimumab in advanced NSCLC: CheckMate 227 subpopulation analyses in Asian patients.
ESMO Open
; 7(1): 100394, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35158207
4.
Fifty years of Sudanese hospital-based obstetric outcomes and an international partnership.
BJOG
; 118(13): 1608-16, 2011 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-21917111
5.
Targeting histone deacetylases for the treatment of disease.
J Cell Mol Med
; 13(5): 826-52, 2009 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-19175682
6.
EUELC project: a multi-centre, multipurpose study to investigate early stage NSCLC, and to establish a biobank for ongoing collaboration.
Eur Respir J
; 34(6): 1477-86, 2009 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-19948914
7.
Randomized phase II study of cetuximab plus cisplatin/vinorelbine compared with cisplatin/vinorelbine alone as first-line therapy in EGFR-expressing advanced non-small-cell lung cancer.
Ann Oncol
; 19(2): 362-9, 2008 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-17947225
8.
Carbonic anhydrase IX expression and outcome after radiotherapy for muscle-invasive bladder cancer.
Clin Oncol (R Coll Radiol)
; 19(10): 777-83, 2007 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-17706406
9.
Toxicity profile of the immunomodulatory thalidomide analogue, lenalidomide: phase I clinical trial of three dosing schedules in patients with solid malignancies.
Eur J Cancer
; 42(14): 2318-25, 2006 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-16899362
10.
EGFR expression: associations with outcome and clinicopathological variables in malignant pleural mesothelioma.
Lung Cancer
; 54(3): 399-407, 2006 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-17049671
11.
Cyclooxygenase-2 protein levels are independent of epidermal growth factor receptor expression or activation in operable non-small cell lung cancer.
Lung Cancer
; 48(1): 47-57, 2005 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-15777970
12.
Matrix metalloproteinase 9 and the epidermal growth factor signal pathway in operable non-small cell lung cancer.
Clin Cancer Res
; 6(6): 2349-55, 2000 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-10873086
13.
Phase I study of the novel cyclic AMP (cAMP) analogue 8-chloro-cAMP in patients with cancer: toxicity, hormonal, and immunological effects.
Clin Cancer Res
; 5(7): 1682-9, 1999 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-10430069
14.
Phase I study of intrapleural batimastat (BB-94), a matrix metalloproteinase inhibitor, in the treatment of malignant pleural effusions.
Clin Cancer Res
; 5(3): 513-20, 1999 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-10100701
15.
A phase II study of razoxane, an antiangiogenic topoisomerase II inhibitor, in renal cell cancer with assessment of potential surrogate markers of angiogenesis.
Clin Cancer Res
; 6(12): 4697-704, 2000 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-11156222
16.
Phase I and pharmacological study of the oral matrix metalloproteinase inhibitor, MMI270 (CGS27023A), in patients with advanced solid cancer.
Clin Cancer Res
; 7(7): 1912-22, 2001 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-11448904
17.
Platinum-based chemotherapy in metastatic breast cancer: the Leicester (U.K.) experience.
Clin Oncol (R Coll Radiol)
; 17(4): 249-57, 2005 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-15997920
18.
A novel cyclic adenosine monophosphate analog induces hypercalcemia via production of 1,25-dihydroxyvitamin D in patients with solid tumors.
J Clin Endocrinol Metab
; 82(12): 4044-8, 1997 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-9398710
19.
Platinum-based chemotherapy in metastatic breast cancer: current status.
Cancer Treat Rev
; 30(1): 53-81, 2004 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-14766126
20.
bcl-2 and c-erbB-2 proteins are involved in the regulation of VEGF and of thymidine phosphorylase angiogenic activity in non-small-cell lung cancer.
Clin Exp Metastasis
; 17(7): 545-54, 1999.
Artigo
em Inglês
| MEDLINE | ID: mdl-10845553